Brugnon Florence, Janny Laurent, Artonne Christine, Sion Benoit, Pouly Jean Luc, Grizard Genevieve
Université Clermont 1, EA975, UFR Médecine, F-63001 Clermont Ferrand Cedex 1, France.
Fertil Steril. 2009 Aug;92(2):557-64. doi: 10.1016/j.fertnstert.2008.07.1712. Epub 2008 Sep 6.
To analyze the expression of activated caspases and membrane permeability in thawed epididymal and testicular spermatozoa of patients with congenital bilateral absence of the vas deferens (CBAVD).
Retrospective study.
Biology and medicine of reproduction in University hospital.
PATIENT(S): Eight CBAVD patients.
INTERVENTION(S): Staining of activated caspases and viability (propidium iodide, PI); intracytoplasmic sperm injection (ICSI).
MAIN OUTCOME MEASURE(S): Proportion of viable (Casp-/PI-) or dead (Casp-/PI+) spermatozoa without activated caspases, viable (Casp+/PI-) or dead (Casp+/PI+) spermatozoa with activated caspases. ICSI results.
RESULT(S): Higher percentage of dead (Casp+/PI+; 84.0% vs. 57.5%) and viable (Casp+/PI-; 12.0% vs. 0) spermatozoa with activated caspases were observed in testicular than in epididymal samples. No significant difference was observed between the percentage of total testicular and epididymal spermatozoa permeant for PI. The outcome of ICSI fertilization (67.5% vs. 57.4%), good morphology embryo at day 2 (75.9% vs. 61.3%), clinical pregnancy (26.7% vs. 15.4%), and implantation (15.6% vs 9.5%) rates were better when ICSI were performed with epididymal sperm samples.
CONCLUSION(S): These results support the hypothesis of an abortive apoptotic process and demonstrate that combined staining of the activated caspases and membrane permeability provide complementary measurements for the evaluation of viable and functional spermatozoa to better understand ICSI outcomes with epididymal and testicular spermatozoa.
分析先天性双侧输精管缺如(CBAVD)患者解冻后的附睾精子和睾丸精子中活化半胱天冬酶的表达及膜通透性。
回顾性研究。
大学医院的生殖生物学与医学研究室。
8例CBAVD患者。
活化半胱天冬酶染色及活力检测(碘化丙啶,PI);卵胞浆内单精子注射(ICSI)。
无活化半胱天冬酶的活精子(Casp-/PI-)或死精子(Casp-/PI+)、有活化半胱天冬酶的活精子(Casp+/PI-)或死精子(Casp+/PI+)的比例。ICSI结果。
在睾丸样本中观察到有活化半胱天冬酶的死精子(Casp+/PI+;84.0%对57.5%)和活精子(Casp+/PI-;12.0%对0)的百分比高于附睾样本。PI可透过的睾丸精子和附睾精子的总百分比之间未观察到显著差异。当使用附睾精子样本进行ICSI时,受精率(67.5%对57.4%)、第2天形态良好的胚胎率(75.9%对61.3%)、临床妊娠率(26.7%对15.4%)和着床率(15.6%对9.5%)更好。
这些结果支持了凋亡过程中止的假说,并表明活化半胱天冬酶和膜通透性的联合染色为评估有活力和功能的精子提供了互补的测量方法,以更好地理解使用附睾精子和睾丸精子进行ICSI的结果。